MET expression and copy number status in clear-cell renal cell carcinoma: prognostic value and potential predictive marker

Multiple targeted therapy for advanced clear-cell renal cell carcinoma (RCC) has substantially improved patient outcome, but complete remission is uncommon and many tumors eventually develop resistance. Mechanistic, preclinical, and early clinical data highlight c-Met / hepatocyte growth factor rece...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Macher-Goeppinger, Stephan, Keith, Martina, Endris, Volker, Penzel, Roland, Tagscherer, Katrin E., Pahernik, Sascha, Hohenfellner, Markus, Gardner, Humphrey, Grüllich, Carsten, Schirmacher, Peter, Roth, Wilfried
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2016
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5352033/
https://ncbi.nlm.nih.gov/pubmed/27894094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13540
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak